The validity of the Hospital Anxiety and Depression Scale. An updated literature review.
I. Bjelland, A. Dahl, T. T. Haug, et al.. (2002). Journal of psychosomatic research. Cited 9,614 times. https://doi.org/10.1016/S0022-3999(01)00296-3A new statistical method for haplotype reconstruction from population data.
M. Stephens, N. J. Smith, P. Donnelly. (2001). American journal of human genetics. Cited 7,788 times. https://doi.org/10.1086/319501A comparison of bayesian methods for haplotype reconstruction from population genotype data.
M. Stephens, P. Donnelly. (2003). American journal of human genetics. Cited 3,663 times. https://doi.org/10.1086/379378International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results.
C. Herrmann. (1997). Journal of psychosomatic research. Cited 3,038 times. https://doi.org/10.1016/S0022-3999(96)00216-4The GDNF family: Signalling, biological functions and therapeutic value
M. S. Airaksinen, M. Saarma. (2002). Nature Reviews Neuroscience. Cited 1,816 times. https://doi.org/10.1038/nrn812Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease
A. Lang, S. Gill, N. Patel, et al.. (2006). Annals of Neurology. Cited 964 times. https://doi.org/10.1002/ana.20737Measures of depression and depressive symptoms: Beck Depression Inventory‐II (BDI‐II), Center for Epidemiologic Studies Depression Scale (CES‐D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire‐9 (PHQ‐9)
K. Smarr, Autumn L. Keefer. (2011). Arthritis Care & Research. Cited 943 times. https://doi.org/10.1002/acr.20556Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
K. Conway, W. Compton, F. Stinson, et al.. (2006). The Journal of clinical psychiatry. Cited 905 times. https://doi.org/10.4088/JCP.V67N0211Gender differences in anxiety disorders and anxiety symptoms in adolescents.
P. Lewinsohn, I. Gotlib, M. Lewinsohn, et al.. (1998). Journal of abnormal psychology. Cited 724 times. https://doi.org/10.1037//0021-843X.107.1.109Epigenetic Status of Gdnf in the Ventral Striatum Determines Susceptibility and Adaptation to Daily Stressful Events
S. Uchida, Kumiko Hara, Ayumi Kobayashi, et al.. (2011). Neuron. Cited 382 times. https://doi.org/10.1016/j.neuron.2010.12.023Gender differences in the epidemiology and treatment of anxiety disorders.
T. Pigott. (1999). The Journal of clinical psychiatry. Cited 363 times.Heritability of anxiety sensitivity: a twin study.
Murray B. Stein, K. Jang, W. Livesley. (1999). The American journal of psychiatry. Cited 282 times. https://doi.org/10.1176/AJP.156.2.246Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo
John L. Hudson, A. Granholm, G. Gerhardt, et al.. (1995). Brain Research Bulletin. Cited 253 times. https://doi.org/10.1016/0361-9230(94)00224-ONicotine, alcohol and drug dependence, and psychiatric comorbidity--results of a national household survey
M. Farrell, S. Howes, P. Bebbington, et al.. (2003). International Review of Psychiatry. Cited 239 times. https://doi.org/10.1080/0954026021000045949BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions
I. Shalev, E. Lerer, S. Israel, et al.. (2009). Psychoneuroendocrinology. Cited 183 times. https://doi.org/10.1016/j.psyneuen.2008.09.017Glial Cell Line-Derived Neurotrophic Factor Is Essential for Postnatal Survival of Midbrain Dopamine Neurons
A. Granholm, M. Reyland, D. Albeck, et al.. (2000). The Journal of Neuroscience. Cited 159 times. https://doi.org/10.1523/JNEUROSCI.20-09-03182.2000Intronic Polymorphisms Affecting Alternative Splicing of Human Dopamine D2 Receptor Are Associated with Cocaine Abuse
R. Moyer, Danxin Wang, A. Papp, et al.. (2011). Neuropsychopharmacology. Cited 145 times. https://doi.org/10.1038/npp.2010.208Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample.
B. Suarez, J. Duan, A. Sanders, et al.. (2006). American journal of human genetics. Cited 130 times. https://doi.org/10.1086/500272Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder
A. Rosa, B. Frey, A. Andreazza, et al.. (2006). Neuroscience Letters. Cited 99 times. https://doi.org/10.1016/j.neulet.2006.08.026Association between depression and the Gln460Arg polymorphism of P2RX7 Gene: A dimensional approach
K. Héjjas, A. Székely, E. Domotor, et al.. (2009). American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. Cited 94 times. https://doi.org/10.1002/ajmg.b.30799Allele variants in functional MicroRNA target sites of the neurotrophin‐3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders
Margarita Muiños-Gimeno, M. Guidi, B. Kagerbauer, et al.. (2009). Human Mutation. Cited 89 times. https://doi.org/10.1002/humu.21005Analysis of the human GDNF gene reveals an inducible promoter, three exons, a triplet repeat within the 3'-UTR and alternative splice products.
L. Grimm, E. Holinski-Feder, J. Teodoridis, et al.. (1998). Human molecular genetics. Cited 81 times. https://doi.org/10.1093/HMG/7.12.1873Characterization of the Intracellular Localization, Processing, and Secretion of Two Glial Cell Line-Derived Neurotrophic Factor Splice Isoforms
Liina Lonka-Nevalaita, M. Lume, Satu Leppänen, et al.. (2010). The Journal of Neuroscience. Cited 77 times. https://doi.org/10.1523/JNEUROSCI.5888-09.2010Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: A comparative post-mortem study
T. Michel, S. Frangou, S. Camara, et al.. (2008). European Psychiatry. Cited 76 times. https://doi.org/10.1016/j.eurpsy.2008.06.001DRD4 exon 3 variants associated with delusional symptomatology in major psychoses: a study on 2,011 affected subjects.
A. Serretti, R. Lilli, C. Lorenzi, et al.. (2001). American journal of medical genetics. Cited 69 times. https://doi.org/10.1002/AJMG.1321Variants in the human insulin gene that affect pre-mRNA splicing: is -23HphI a functional single nucleotide polymorphism at IDDM2?
J. Královičová, Tom R. Gaunt, S. Rodríguez, et al.. (2006). Diabetes. Cited 64 times. https://doi.org/10.2337/DIABETES.55.01.06.DB05-0773Validation of the Hungarian Translation of Hospital Anxiety and Depression Scale
Katalin Muszbek, A. Székely, É. Balogh, et al.. (2006). Quality of Life Research. Cited 61 times. https://doi.org/10.1007/s11136-005-3627-8An investigation of the neurotrophic factor genes GDNF, NGF, and NT3 in susceptibility to ADHD
Zahoor Syed, F. Dudbridge, L. Kent. (2007). American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. Cited 60 times. https://doi.org/10.1002/ajmg.b.30459Association study between plasma GDNF and cognitive function in late-onset depression.
Xiaoquan Wang, Z. Hou, Yonggui Yuan, et al.. (2011). Journal of affective disorders. Cited 56 times. https://doi.org/10.1016/j.jad.2011.03.043Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patients.
Xiaobin Zhang, Zhijun Zhang, Wei-wei Sha, et al.. (2010). Journal of affective disorders. Cited 54 times. https://doi.org/10.1016/j.jad.2010.03.003Chronic clomipramine treatment restores hippocampal expression of glial cell line-derived neurotrophic factor in a rat model of depression.
Qiong Liu, Hai-yan Zhu, Bing Li, et al.. (2012). Journal of affective disorders. Cited 51 times. https://doi.org/10.1016/j.jad.2012.03.018Antidepressants elevate GDNF expression and release from C₆ glioma cells in a β-arrestin1-dependent, CREB interactive pathway.
M. Golan, G. Schreiber, S. Avissar. (2011). The international journal of neuropsychopharmacology. Cited 51 times. https://doi.org/10.1017/S1461145710001550Age-associated decrease in serum glial cell line-derived neurotrophic factor levels in patients with major depressive disorder
P. Tseng, Yu Lee, Pao-Yen Lin. (2013). Progress in Neuro-Psychopharmacology and Biological Psychiatry. Cited 45 times. https://doi.org/10.1016/j.pnpbp.2012.09.009P2RX7 Gln460Arg polymorphism is associated with depression among diabetic patients
G. Nagy, Z. Rónai, A. Somogyi, et al.. (2008). Progress in Neuro-Psychopharmacology and Biological Psychiatry. Cited 45 times. https://doi.org/10.1016/j.pnpbp.2008.08.021VAL66MET BDNF GENOTYPES IN MELANCHOLIC DEPRESSION: EFFECTS ON BRAIN STRUCTURE AND TREATMENT OUTCOME
N. Cardoner, V. Soria, M. Gratacós, et al.. (2013). Depression and Anxiety. Cited 44 times. https://doi.org/10.1002/da.22025Noninvasive genotyping of dopamine receptor D4 (DRD4) using nanograms of DNA from substance-dependent patients.
K. Boór, Z. Rónai, Z. Nemoda, et al.. (2002). Current medicinal chemistry. Cited 44 times. https://doi.org/10.2174/0929867024606821Hydrophobic dipeptide Leu‐Ile protects against neuronal death by inducing brain‐derived neurotrophic factor and glial cell line‐derived neurotrophic factor synthesis
A. Nitta, H. Nishioka, H. Fukumitsu, et al.. (2004). Journal of Neuroscience Research. Cited 40 times. https://doi.org/10.1002/jnr.20258Hormonal interventions with psychopharmacological potential: an overview.
U. Halbreich. (1997). Psychopharmacology bulletin. Cited 39 times.3′ UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia
Anna Michelato, C. Bonvicini, M. Ventriglia, et al.. (2004). Neuroscience Letters. Cited 31 times. https://doi.org/10.1016/j.neulet.2003.12.089Glial cell line-derived neurotrophic factor (GDNF) gene and schizophrenia: polymorphism screening and association analysis
K. Lee, H. Kunugi, S. Nanko. (2001). Psychiatry Research. Cited 30 times. https://doi.org/10.1016/S0165-1781(01)00294-3The interaction between Comt and Bdnf variants influences obsessive-compulsive-related dysfunctional beliefs.
P. Alonso, C. López-Solà, M. Gratacós, et al.. (2013). Journal of anxiety disorders. Cited 20 times. https://doi.org/10.1016/j.janxdis.2013.02.012Association analysis of the glial cell line-derived neurotrophic factor (GDNF) gene in schizophrenia
Hywel Williams, Nadine Norton, T. Peirce, et al.. (2007). Schizophrenia Research. Cited 18 times. https://doi.org/10.1016/j.schres.2007.09.004Dopamine D2 receptor activation leads to an up‐regulation of glial cell line–derived neurotrophic factor via Gβγ‐Erk1/2‐dependent induction of Zif268
Somayeh Ahmadiantehrani, D. Ron. (2013). Journal of Neurochemistry. Cited 13 times. https://doi.org/10.1111/jnc.12178Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population
Tomoko Yoshimura, Hinako Usui, N. Takahashi, et al.. (2011). Progress in Neuro-Psychopharmacology and Biological Psychiatry. Cited 12 times. https://doi.org/10.1016/j.pnpbp.2011.04.003A few nucleotide polymorphisms are sufficient to recruit nuclear factors differentially to the intron 1 of HPV-16 intratypic variants.
E. López-Urrutia, J. Valdés, Raúl Bonilla‐Moreno, et al.. (2012). Virus research. Cited 12 times. https://doi.org/10.1016/j.virusres.2012.02.026Pharmaco- and therapygenetic aspects in the treatment of anxiety disorders beyond the serotonergic system: a brief review.
G. Faludi, X. Gonda, G. Bagdy, et al.. (2012). Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology. Cited 7 times.Polymorphisms in an intronic region of the myocilin gene associated with primary open-angle glaucoma—a possible role for alternate splicing
P. E. Pandaranayaka, N. Prasanthi, N. Kannabiran, et al.. (2010). Molecular Vision. Cited 5 times.